ANGEL YEAST(SH:600298)2024-02-07 07:54Group 1: Company Strategy and Development - The establishment of a wholly-owned subsidiary, Anqi Sales Company, aims to enhance operational efficiency and mitigate trade risks, thereby broadening the company's main business scope and improving market competitiveness [1] - The PHA project is currently in its initial stage, with an overall production capacity planned at 3,000 tons per year [1][2] Group 2: Enzyme Preparations and Market Position - Enzyme preparations are a key business unit for the company, characterized by their green, efficient, and safe properties, applicable across various industries such as food, cleaning, bioenergy, and pharmaceuticals [2] - The company has developed multiple enzyme products that meet market demands and plans to continue product development to increase market share [2] Group 3: Financial Performance and Dividends - The company distributed cash dividends totaling 430 million yuan last year and intends to steadily increase the dividend ratio based on overall business conditions [2] Group 4: Future Expansion Plans - Currently, there are no plans to establish a factory in Brazil; however, the company aims to set up an overseas warehouse and sales team in Brazil to facilitate direct supply to major clients [2] Group 5: Investor Communication and Compliance - The company ensured thorough communication with investors during the meeting, adhering strictly to regulations to prevent the disclosure of any undisclosed significant information [3]